12 December 2011
DoReMi WP2 Questionnaire
for organizations/groups conducting low dose research
The purpose of this questionnaire is to identify national research groups or institutions
interested in low dose radiation risk research that are willing to act as contact points in this
area. If your organization wishes to show its interest in the low dose risk area, you are welcome
to provide information on your capabilities by filling in the questionnaire. This voluntary
information contributes to the survey of existing research and competencies in Europe. The
responders will receive DoReMi Newsletters as well as information on the activities of DoReMi
and MELODI, such as research agendas, calls, workshops and training events.
Please fill in the form (see below) and send it by e-mail to:
- The project Coordinator: Sisko Salomaa, STUK, Helsinki, Finland (sisko.salomaa@stuk.fi)
- The responsible person for the work done on the DoReMi TRA and on structuring the platform
MELODI: Dietrich Averbeck, IRSN/CEA, Fontenay-aux-Roses, France (dietrich.averbeck@irsn.fr).
All questions regarding this questionnaire should be directed to Dr. Averbeck. Your information
will be treated as confidential and the contact information will be used for DoReMi and MELODI
distribution lists only.
The DoReMi network wishes to thank all those that respond to the questionnaire. A summary of
the results of the survey will be provided by IRSN. By today, more than 100 researchers have
replied and the information collected has been very useful to inform and to attract new
interested partners to take part in DoReMi meetings and MELODI workshops (2nd and 3rd) as
well calls for research. The survey also serves as a basis for the identification of infrastructures
and national funding possibilities for low dose research.
1
DoReMi WP2 Questionnaire
Partner’s full institutional address:
Name of your organisation:
Address (Organization,Institution/Laboratory):
Country:
Phone:
Fax:
E-Mail:
Web-site (if applicable):
Date of response (dd/mm/yy):
Name of the person who completed the questionnaire:
First name (initials):
Surname:
Position in organisation:
For each question, please check the box
when your answer is yes.
1a. Within your research institution and/or unit how many researchers participate (>50%of
time) in projects dedicated to radiation science
5-10 researchers
10-20 researchers
20- 50 researchers
50-100 researchers
> 100 researchers
1b. Of these, how many are directly involved in projects pertaining to low dose risk?
5-10 researchers
10-20 researchers
20- 50 researchers
50-100 researchers
100 researchers
>100 researchers
2. Your research institution and/or laboratory is committed to sustain (at least in part)
Short term low dose research
< 5 years
Middlelong term low dose research
> 5-10 years
Long term low dose research
> 10-20 years
3a. Your laboratory and/or institution is already involved in low dose radiation research
(experimental or/and epidemiological studies considering exposures to doses below 100 mSv).
2
3b. If yes, list below (max five) publications from your low dose radiation
Research
References:
(1)
(2)
(3)
(4)
(5)
4. You are working with
high LET radiation
low LET radiation
at present
in the near future
at present
in the near future
5. You are involved in research work on
low dose (<100 mGy)
medium dose (100mGy – 2Gy)
high dose (> 2 Gy)
external exposure
internal exposure (contamination with radionuclides
- Uranium
- Strontium
- Tritium
- Cesium
- Others (please, specify)…………………………
……………………………………………………………………………………
……………………………………………………………………………………
……………………………………………………………………………………
chronic (low dose rate) exposure
fractionated exposure
low dose rate (< 20 mGy/min)
high dose rate (> 2 mGy/min)
microbeam exposures
6. You are involved in research work on
molecules
cells
tissues
organs
animals
mice
rats
guinea pigs
others (please,specify)…………………………………
……………………………………………………………………………………
……………………………………………………………………………………
……………………………………………………………………………………
man
7. Your research institution and/or laboratory offers
Radiation research infrastructures
specify:
Is your platform open to other users
3
8. Your institution and/or laboratory is part of a platform engaged in
Epidemiology (trans-national cohorts)
Data bases and tissue banks
Platforms of analysis (“omics”)
9. Your institution and/or research laboratory is already engaged
in teaching & training of radiation research
in university courses on radiation biology
10. Your research institution and/or laboratory is involved
in research work on the following themes:
at present
in the future
Risks and Radiation dose-responses for cancer
Tissue sensitivities for cancer
Individual variability
Effects of radiation quality
Risks from external exposure
Risks and dose-response relationships
for non –cancer diseases
Others (please, specify)………………
at present
in the future
……………………………………………………………………..
……………………………………………………………………..
……………………………………………………………………..
……………………………………………………………………..
11. Is your research institution and /or laboratory involved in providing advice/expertise or
consulting
on radiation research issues
at a national level
at an international level
on the evaluation of radiation health risks
at a national level
at an international level
12. Your research institution and/or laboratory has experience in
the dissemination of research project outcomes
the evaluation of radiation health risks
13. Your research institution and/or laboratory is interested in
fundamental research
applied medical research
applied industrial research
environmental research issues
4
molecular epidemiology
modelling
systems biology
14. Your published work concerns
to
% fundamental research
to
% applied medical research
to
% applied industrial research
to
% environmental research issues
to
% molecular epidemiology
to
% modelling
to
% systems biology
15. Has your research institution and/or laboratory been already involved in EU (FP3-FP7)
projects on low dose research.
national
international
Please
provide
the
names
………………………………………...........................................
………………………………………………………………………
………………………………………………………………………
………………………………………………………………………
………………………………………………………………………
and
acronyms
of
the
projects:
16. Has your research institution and/or laboratory been already involved in EU (FP3-FP7)
projects on low dose research (ONLY YES OR NO) at national level not funded by EURATOM
16a Have you participated in multipartner research projects/initiatives or in a transnational
consortium
17. Please indicate below any additional information that might be useful to people who read
this questionnaire:
………………………………………………………………………
………………………………………………………………………
………………………………………………………………………
………………………………………………………………………
………………………………………………………………………
………………………………………………………………………
5